DE60122488D1 - Verwendung des menschlichen Latrophilin-like G Protein-coupled Receptor in Screenings-Verfahren - Google Patents
Verwendung des menschlichen Latrophilin-like G Protein-coupled Receptor in Screenings-VerfahrenInfo
- Publication number
- DE60122488D1 DE60122488D1 DE60122488T DE60122488T DE60122488D1 DE 60122488 D1 DE60122488 D1 DE 60122488D1 DE 60122488 T DE60122488 T DE 60122488T DE 60122488 T DE60122488 T DE 60122488T DE 60122488 D1 DE60122488 D1 DE 60122488D1
- Authority
- DE
- Germany
- Prior art keywords
- protein
- coupled receptor
- human
- screening procedures
- latrophilin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 title abstract 2
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 1
- 238000012216 screening Methods 0.000 title 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 230000001594 aberrant effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000004064 dysfunction Effects 0.000 abstract 1
- 210000000750 endocrine system Anatomy 0.000 abstract 1
- 230000028023 exocytosis Effects 0.000 abstract 1
- 210000000653 nervous system Anatomy 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19110300P | 2000-03-22 | 2000-03-22 | |
| US191103P | 2000-03-22 | ||
| US21074500P | 2000-06-12 | 2000-06-12 | |
| US210745P | 2000-06-12 | ||
| PCT/EP2001/003223 WO2001070969A2 (en) | 2000-03-22 | 2001-03-21 | Regulation of human latrophilin-like g protein-coupled receptor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60122488D1 true DE60122488D1 (de) | 2006-10-05 |
| DE60122488T2 DE60122488T2 (de) | 2007-10-04 |
Family
ID=26886755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60122488T Expired - Fee Related DE60122488T2 (de) | 2000-03-22 | 2001-03-21 | Verwendung des menschlichen Latrophilin-like G Protein-coupled Receptor in Screenings-Verfahren |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20040175698A1 (de) |
| EP (1) | EP1276867B1 (de) |
| AT (1) | ATE337398T1 (de) |
| AU (1) | AU2001263796A1 (de) |
| CY (1) | CY1105656T1 (de) |
| DE (1) | DE60122488T2 (de) |
| DK (1) | DK1276867T3 (de) |
| ES (1) | ES2271020T3 (de) |
| PT (1) | PT1276867E (de) |
| WO (1) | WO2001070969A2 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004018516A1 (en) * | 2002-08-19 | 2004-03-04 | Bayer Healthcare Ag | Regulation of human secretin-type gpcr (latrophilin) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001229340A1 (en) * | 2000-01-14 | 2001-07-24 | Millennium Pharmaceuticals, Inc. | Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
-
2001
- 2001-03-21 PT PT01938027T patent/PT1276867E/pt unknown
- 2001-03-21 WO PCT/EP2001/003223 patent/WO2001070969A2/en not_active Ceased
- 2001-03-21 EP EP01938027A patent/EP1276867B1/de not_active Expired - Lifetime
- 2001-03-21 ES ES01938027T patent/ES2271020T3/es not_active Expired - Lifetime
- 2001-03-21 AT AT01938027T patent/ATE337398T1/de not_active IP Right Cessation
- 2001-03-21 AU AU2001263796A patent/AU2001263796A1/en not_active Abandoned
- 2001-03-21 DK DK01938027T patent/DK1276867T3/da active
- 2001-03-21 DE DE60122488T patent/DE60122488T2/de not_active Expired - Fee Related
- 2001-03-21 US US10/221,159 patent/US20040175698A1/en not_active Abandoned
-
2006
- 2006-10-12 CY CY20061101459T patent/CY1105656T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE337398T1 (de) | 2006-09-15 |
| DE60122488T2 (de) | 2007-10-04 |
| US20040175698A1 (en) | 2004-09-09 |
| EP1276867A2 (de) | 2003-01-22 |
| EP1276867B1 (de) | 2006-08-23 |
| PT1276867E (pt) | 2006-12-29 |
| WO2001070969A3 (en) | 2002-09-26 |
| CY1105656T1 (el) | 2010-12-22 |
| WO2001070969A2 (en) | 2001-09-27 |
| AU2001263796A1 (en) | 2001-10-03 |
| ES2271020T3 (es) | 2007-04-16 |
| DK1276867T3 (da) | 2007-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL184749A0 (en) | Anti-interferon gamma antibodies and pharmaceutical compositions containing the same | |
| BR0313792A (pt) | Utilização de proteìna de eritropoetina, método para tratamento de distúrbios de distribuição de ferro em diabetes e medicamento para o seu tratamento | |
| DK1112362T3 (da) | Genforandring i genet for G$g(b)3-underenheden i det menneskelige G-protein | |
| WO2004081043A3 (en) | Baff mutants with at least one amino acid substitution and methods of their production | |
| MXPA05009743A (es) | Composiciones con actividad hematopoyetica e inmune. | |
| EP1207198A4 (de) | G-protein gekoppeltes rezeptorprotein und dessen dna | |
| YU68602A (sh) | Monoklonska antitela na humani ldl receptor, njihova produkcija i korišćenje | |
| DE60122488D1 (de) | Verwendung des menschlichen Latrophilin-like G Protein-coupled Receptor in Screenings-Verfahren | |
| TW200503717A (en) | Substituted 1,4-pyrazine derivatives | |
| WO2002072824A3 (en) | Human transient receptor potential channel protein. | |
| SG146640A1 (en) | Isolated photoprotein mtclytin, and use thereof | |
| WO2001070954A3 (en) | Regulation of human nerve growth factor-elated g protein-coupled receptor | |
| WO2001092503A3 (en) | Regulation of human calcium-independent alpha-latro-toxin-like g protein-coupled receptor | |
| NO20024779L (no) | G-protein-koblet reseptor | |
| NZ514691A (en) | Method to type prion proteins | |
| AU2003229767A8 (en) | Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9) | |
| WO2001014415A3 (en) | Egfh2 genes and gene products | |
| GB0217548D0 (en) | Four human zinc-finger-containing proteins:MDZ3.MDZ4,MDZ7 and MDZ12 | |
| AU2003229736A1 (en) | Diagnostics and therapeutics for diseases associated with neurotensin receptor 1 (nt1) | |
| WO2002081705A3 (en) | Regulation of human gnat acetyltransferase-like protein | |
| AU2003229753A1 (en) | Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8) | |
| WO2004009633A8 (en) | Serotonin receptor | |
| WO2002046403A3 (en) | Regulation of human patched-like protein | |
| WO2002029048A3 (en) | Regulation of human sodium-dependent neurotransmitter transporter | |
| WO2002053749A3 (en) | Regulation of human serine-threonine protein kinase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |